Ropeginterferon alfa-2b
罗培干扰素α-2b
Report date: 2026/05/20 20:02:01
First In Class
Base Information
Drug NameRopeginterferon alfa-2b
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2019/02/15
Country/Territory +[25]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPharmaEssentia Corp
China Registration ClassN/A
Develop Information
Active CompaniesUtah State UniversityPharmaEssentia Biotechnology（Beijing）Co LtdAop Orphan Pharmaceuticals GmbH +[11]
Inactive CompaniesMycenax Biotech IncPharmaessentia Corp Taichung PlantPharmaessentia Corporation (Co-Sponsor For Usa)
Active Indications +[11]
Inactive Indications